A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

Clinical trial NCT05101356 · SUSPENDED

Trial details

NCT number: NCT05101356
Sponsor: University of California, Davis
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Adenocarcinoma Advanced Malignant Solid Neoplasm Metastatic Adenocarcinoma Metastatic Malignant Solid Neoplasm Recurrent Adenocarcinoma Recurrent Malignant Solid Neoplasm

Start date: 2021-01-13
Primary completion: 2030-12-31
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.